Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately ...

Azalea's first drug candidate is a CAR-T therapy for cancer and autoimmune conditions that turns immune cells into cancer ...

Regulatory mechanisms governing stem cell quiescence in glandular organs remain ill-defined. Here, multi-omics profiling ...

TIL therapy uses a patient’s own immune cells to attack cancer cells. The process involves extracting cells from their tumor, ...

HF outcomes at 3 years were improved, but where stem cells fit in future research is the big unknown, says Jay Traverse.

Researchers at NYU said that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung ...

Cancer treatment has always been a balancing act—hit the tumor hard enough to kill it, but not so hard that the patient ...

An Osaka Metropolitan University team has used stem cells extracted from adipose, the body's fatty tissue, to treat spine fractures in rats similar to those caused by osteoporosis in humans. These ...

Since the beginning of this century, advances in understanding the biology of multiple myeloma have transformed the disease ...

A lower number of CD26+ LSCs at diagnosis correlates with optimal molecular response in CML patients at 3, 12, and 24 months.

Progress has been made in identifying and treating the disease, but the impact of federal cuts is yet to be borne out.

Scientists have successfully created immature human egg-like cells from skin-derived stem cells, a significant step in ...